Home › Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis clinical trials recruiting in the U.S.

29 studies for Idiopathic Pulmonary Fibrosis are recruiting participants at sites across the United States.

Cities with the most studies

• Philadelphia, PA9 studies
• Birmingham, AL8 studies
• New York City, NY7 studies
• Los Angeles, CA6 studies
• Chicago, IL6 studies
• Kansas City, KS6 studies
• Durham, NC6 studies
• Aurora, CO6 studies
• Winston-Salem, NC5 studies
• Nashville, TN5 studies
• Houston, TX5 studies
• El Paso, TX5 studies
• Atlanta, GA5 studies
• Dallas, TX4 studies
• Orlando, FL4 studies
• Charlotte, NC4 studies
• Detroit, MI4 studies
• Charleston, SC4 studies
• Greensboro, NC4 studies
• Oklahoma City, OK3 studies
• Mountain View, CA3 studies
• Bend, OR3 studies
• Hartford, CT3 studies
• Miami, FL3 studies
• Denison, TX3 studies
• Portland, OR3 studies
• New Haven, CT3 studies
• Cincinnati, OH3 studies
• Salt Lake City, UT3 studies
• Ann Arbor, MI3 studies
• Richmond, VA3 studies
• Arlington, VA3 studies
• Lexington, KY3 studies
• Newport Beach, CA3 studies
• Baltimore, MD3 studies
• Charlottesville, VA3 studies
• Tampa, FL3 studies

By state

• Alabama10 studies
• Arizona4 studies
• California12 studies
• Colorado8 studies
• Connecticut5 studies
• Florida13 studies
• Georgia5 studies
• Illinois7 studies
• Kansas6 studies
• Kentucky4 studies
• Louisiana3 studies
• Maryland4 studies
• Massachusetts3 studies
• Michigan7 studies
• Minnesota3 studies
• Missouri7 studies
• New York8 studies
• North Carolina11 studies
• Ohio5 studies
• Oklahoma4 studies
• Oregon4 studies
• Pennsylvania12 studies
• South Carolina8 studies
• Tennessee6 studies
• Texas11 studies
• Utah5 studies
• Virginia8 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.